Opioid-induced hyperalgesia as a problem in pain management. Mechanisms of onset, diagnosis and treatment
Zbigniew Zylicz, Małgorzata Krajnik
Advances in Palliative Medicine 2007;6(1):37-44.
open access
Vol 6, No 1 (2007)
Review articles
Published online: 2007-02-22
Abstract
Opioids have been used for centuries to control pain. One of the problems with their use is the development
of tolerance in some patients. This problem is usually solved by an increase in the dose. However, this does
not solve all the difficulties encountered. In some patients, the opioid doses needs rise very quickly. It seems
that this phenomenon depends on changes in the opioid receptors and on the organization of the functions
of the central nervous system. This phenomenon is known as opioid-induced hyperalgesia. Changes may
include the facilitation of pain conveyance which may more or less counteract the analgesic effect of the
same drug. Until now, several putative mechanisms have been identified. Here we shall explore the changes
of opioid receptors and changes in the glutaminergic system. In addition, the spinal cord and probably also
the liver are producing a specific peptide, Dynorphin A, which has an excitatory effect. The organization and
function of the On-Off cells in the brain are also changed. In this article, we discuss strategies for the
treatment of opioid-induced hyperalgesia. These strategies have the potential to improve the quality of
opioid analgesia.
Abstract
Opioids have been used for centuries to control pain. One of the problems with their use is the development
of tolerance in some patients. This problem is usually solved by an increase in the dose. However, this does
not solve all the difficulties encountered. In some patients, the opioid doses needs rise very quickly. It seems
that this phenomenon depends on changes in the opioid receptors and on the organization of the functions
of the central nervous system. This phenomenon is known as opioid-induced hyperalgesia. Changes may
include the facilitation of pain conveyance which may more or less counteract the analgesic effect of the
same drug. Until now, several putative mechanisms have been identified. Here we shall explore the changes
of opioid receptors and changes in the glutaminergic system. In addition, the spinal cord and probably also
the liver are producing a specific peptide, Dynorphin A, which has an excitatory effect. The organization and
function of the On-Off cells in the brain are also changed. In this article, we discuss strategies for the
treatment of opioid-induced hyperalgesia. These strategies have the potential to improve the quality of
opioid analgesia.